OxERA® DEVICE
The OxERA device arose as a by-product of our BiPAP prototype system and has now evolved into a separate stand-alone device that has proven remarkably effective at treating COVID-19 pneumonia. We have found that the overwhelming need of COVID-19 pneumonia patients is oxygen. In very sick patients, this typically needs to be 100%O2. The differences […]
The Oxygen Dilemma
South Africa faces a new variant of Covid amidst a second wave. Speculation surrounds the wave’s momentum which is feared to be greater than our first. Numbers are increasing, hospitals are saturated and oxygen is a sort-after yet life-saving resource. Patients with Covid pulmonary disease and cardiac complications require oxygen, and more often than not […]
Breathe in, hold, breathe out
Breathe in, hold, breathe out… A simple, subconscious action that our very lives depend on entirely, at times taken for granted in its subtlety. Air, the breath of life, comprised of 21%-part Oxygen, 78%-part Nitrogen, and tiny amounts of other gases like Argon, Methane, and Carbon Dioxide. The very anatomical and physiological nature of breathing […]
Second Round of NVP Evaluation
Quick update on progress – the Umoya teams solutions for a non-invasive ventilator and alternative air supply are through to the next round of evaluation as part of the governments NVP programme mentioned by Cyril Ramaphosa last week. This has only been possible through the hard work and time commitments of some incredible individuals and […]